107
report
Landscape of Trust: Health Data Frameworks
The rapid advancement of the health technology landscape relies heavily on patient data.
report
Models for Financing Antibiotic Development to Address Antimicrobial Resistance
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to id
report
Type 1 Diabetes Autoantibody Screening Implementation Roadmap: 2022 REPORT UPDATE
In April 2021, the Milken Institute, with generous funding from the Leona M. and Harry B. Helmsley
Charitable Trust, published a report focused on the implementation of type 1 diabetes (T1D) autoantibody screening in the general population.
+ Read More
report
Consensus Definition of Misophonia A Delphi Study
Misophonia was named and described in the early 2000’s (Jastreboff and Jastreboff, 2001, 2002) and
has since gained scientific recognition and clinical identification across a wide variety of disciplines (e.g., audiology, neuroscience, occupational ther
+ Read More
podcast episode
Ep. 126: Who We Are Today, With Ancestry’s Deb Liu
“How do we think about building an inclusive product that represents what families look like today
, which might be very different than what families looked like 200 years ago. We want voices from all over to help us shape that product.”
+ Read More
panel
Closing Networking Reception
panel
Networking Break
panel
Asset Owners’ Outlook: Priorities and Perspectives on Long-Term Value Creation (Invite only)
Global asset owners today have their work cut out for them as they consider capital allocation d
ecisions.
+ Read More
panel
Global Investors’ View: China (Invite only)
Beijing has gone above and beyond its normal policy practices to boost investor confidence. Stim
ulus packages, interest rate cuts, and local bond issuances are several of the levers it pulled to boost domestic economic activity.
+ Read More
panel
Forum for Family Asset Management Roundtable: How Global Shifts are Reshaping Family Office Allocations (Invite only)
In today’s global environment, how are family offices recalibrating investment strategies amid g
lobal shifts, rising protectionism, regulatory changes, and macroeconomic uncertainty?
+ Read More